EE9900105A - Bensonaftüridiinid bronhiaalravimitena - Google Patents

Bensonaftüridiinid bronhiaalravimitena

Info

Publication number
EE9900105A
EE9900105A EEP199900105A EE9900105A EE9900105A EE 9900105 A EE9900105 A EE 9900105A EE P199900105 A EEP199900105 A EE P199900105A EE 9900105 A EE9900105 A EE 9900105A EE 9900105 A EE9900105 A EE 9900105A
Authority
EE
Estonia
Prior art keywords
pct
benzonaphthyridines
bronchodilators
date
sec
Prior art date
Application number
EEP199900105A
Other languages
English (en)
Other versions
EE03829B1 (et
Inventor
Gutterer Beate
Amschler Hermann
Ulrich Wolf-R�diger
Martin Thomas
B�r Thomas
Hatzelmann Armin
Sanders Karl
Beume Rolf
Boss Hildegard
H�fner Dietrich
Kley Hans-Peter
Goebel Karl-Josef
Original Assignee
Byk Gulden Lomberg Chemische Fabrik Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Byk Gulden Lomberg Chemische Fabrik Gmbh filed Critical Byk Gulden Lomberg Chemische Fabrik Gmbh
Publication of EE9900105A publication Critical patent/EE9900105A/et
Publication of EE03829B1 publication Critical patent/EE03829B1/et

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Pulmonology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Cardiology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrane Compounds (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
EEP199900105A 1996-11-11 1997-11-05 Bensonaftüridiinid, nende kasutamine bronhiaalravimi valmistamiseks ning neid sisaldav ravim EE03829B1 (et)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE19646298 1996-11-11
EP96118188 1996-11-13
DE19739056 1997-09-05
PCT/EP1997/006096 WO1998021208A1 (en) 1996-11-11 1997-11-05 Benzonaphthyridines as bronchial therapeutics

Publications (2)

Publication Number Publication Date
EE9900105A true EE9900105A (et) 1999-10-15
EE03829B1 EE03829B1 (et) 2002-08-15

Family

ID=27216810

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP199900105A EE03829B1 (et) 1996-11-11 1997-11-05 Bensonaftüridiinid, nende kasutamine bronhiaalravimi valmistamiseks ning neid sisaldav ravim

Country Status (30)

Country Link
US (1) US6008215A (et)
EP (1) EP0937074B1 (et)
JP (1) JP4223075B2 (et)
KR (1) KR100484045B1 (et)
CN (1) CN1090188C (et)
AT (1) ATE234300T1 (et)
AU (1) AU733129B2 (et)
BG (1) BG63695B1 (et)
BR (1) BR9713338B1 (et)
CA (1) CA2270964C (et)
CY (1) CY2476B1 (et)
CZ (1) CZ288752B6 (et)
DE (1) DE69719778T2 (et)
DK (1) DK0937074T3 (et)
EA (1) EA001551B1 (et)
EE (1) EE03829B1 (et)
ES (1) ES2195189T3 (et)
GE (1) GEP20012390B (et)
HU (1) HU226981B1 (et)
ID (1) ID22042A (et)
IL (1) IL129054A (et)
NO (1) NO312764B1 (et)
NZ (1) NZ334976A (et)
PL (1) PL189641B1 (et)
PT (1) PT937074E (et)
RS (1) RS49607B (et)
SI (1) SI0937074T1 (et)
SK (1) SK283269B6 (et)
TR (1) TR199900856T2 (et)
WO (1) WO1998021208A1 (et)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1075477T3 (da) 1998-05-05 2003-06-30 Altana Pharma Ag Nye benzonaphthyridin-N-oxider
AU5970199A (en) * 1998-08-31 2000-03-21 Byk Gulden Lomberg Chemische Fabrik Gmbh Benzonaphthyridine-n-oxides comprising a pde3 and pde4 inhibiting activity
IT1303272B1 (it) * 1998-10-29 2000-11-06 Zambon Spa Derivati triciclici inibitori della fosfodiesterasi 4
CA2360386A1 (en) 1999-01-15 2000-07-20 Beate Gutterer Polysubstituted 6-phenylphenanthridines with pde-iv inhibiting activity
DE60020079T2 (de) 1999-01-15 2006-01-19 Altana Pharma Ag Phenanthridin-N-oxide mit PDE-IV-hemmender Wirkung
ES2241571T3 (es) 1999-01-15 2005-11-01 Altana Pharma Ag N-oxidos de fenantrinida con actividad inhividora de pde-iv.
TR200501553T2 (tr) 1999-01-15 2005-06-21 Altana Pharma Ag PDE-IV inhibe edici aktivitesi olan fenilfenantridinler
CA2715683A1 (en) * 1999-08-21 2001-03-01 Nycomed Gmbh Synergistic combination
NL1017973C2 (nl) * 2000-05-10 2002-11-08 Tristem Trading Cyprus Ltd Inrichting.
US6936622B2 (en) 2001-02-21 2005-08-30 Altana Pharma Ag 6-phenylbenzonaphthyridines
US6479493B1 (en) 2001-08-23 2002-11-12 Cell Pathways, Inc. Methods for treatment of type I diabetes
RS20050117A (sr) * 2002-08-17 2007-06-04 Altana Pharma Ag., Novi benzonaftiridini
HRP20050293A2 (en) 2002-09-04 2006-07-31 Altana Pharma Ag Novel benzonaphthyridines
PL373989A1 (en) * 2002-09-04 2005-09-19 Altana Pharma Ag Novel benzonaphthyridines
US7153824B2 (en) 2003-04-01 2006-12-26 Applied Research Systems Ars Holding N.V. Inhibitors of phosphodiesterases in infertility
AR049419A1 (es) * 2004-03-03 2006-08-02 Altana Pharma Ag Hidroxi-6-fenilfenantridinas sustituidas con heterociclilo
PL2589599T4 (pl) 2004-03-03 2015-06-30 Takeda Gmbh Nowe hydroksy-6-heteroarylofenantrydyny i ich zastosowanie jako inhibitorów PDE4
EP1725534A1 (en) * 2004-03-10 2006-11-29 Altana Pharma AG Novel amido-substituted hydroxy-6-phenylphenanthridines and their use as pde4 inhibitors
US7671068B2 (en) 2004-03-17 2010-03-02 Nycomed Gmbh N-(alkoxyalkyl) carbamoyl-substituted 6-phenyl-benzonaphthyridine derivatives and their use as PDE ¾ inhibitors
EP1791847A2 (en) 2004-09-08 2007-06-06 Altana Pharma AG Novel 3-thia-10-aza-phenanthrene derivatives
ATE508130T1 (de) * 2004-09-08 2011-05-15 Nycomed Gmbh 3-oxa-10-aza-phenanthrene als pde4- oder pde3/4- inhibitoren
PL1856093T3 (pl) 2005-03-02 2010-05-31 Takeda Gmbh Chlorowodorek (2R,4aR,10bR)-6-(2,6-dimetoksy-pirydyn-3-ylo)-9-etoksy-8-metoksy-1,2,3,4,4a,10b-heksahydrofenantrydyn-2-olu
AU2006305619A1 (en) 2005-10-19 2007-04-26 Ranbaxy Laboratories Limited Pharmaceutical compositions of muscarinic receptor antagonists
TW200808695A (en) * 2006-06-08 2008-02-16 Amgen Inc Benzamide derivatives and uses related thereto
BRPI0719123A2 (pt) * 2006-09-01 2013-12-17 Cylene Pharmaceuticals Inc Moduladores de serina-treonina proteína cinase e parp
BRPI0911681B8 (pt) 2008-04-23 2021-05-25 Rigel Pharmaceuticals Inc composto, composição farmacêutica, e, método para ativar a via de proteína quinase ativada por 5'-amp em uma célula in vitro
AR079451A1 (es) 2009-12-18 2012-01-25 Nycomed Gmbh Compuestos 3,4,4a,10b-tetrahidro-1h-tiopirano[4,3-c]isoquinolina
CN108299429B (zh) * 2018-04-09 2021-10-08 中南大学 一类八氢苯并萘啶化合物及其制备方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3899494A (en) * 1970-05-13 1975-08-12 Sandoz Ltd Substituted 6-phenyl benzo-naphthyridines
EP0247971A3 (en) * 1986-05-29 1990-01-17 Sandoz Ag Novel pharmaceutical compositions comprising and use of cis-6-(4-acetanilido)-8,9-dimethoxy-2-methyl-1,2,3,4,4a,10b-hexahydrobenzo[c][1,6]naphthyridin
MY105344A (en) * 1990-05-16 1994-09-30 Byk Gulden Lomberg Chemische Fabrik New sulphonyl compounds

Also Published As

Publication number Publication date
PT937074E (pt) 2003-07-31
SK283269B6 (sk) 2003-04-01
CN1236367A (zh) 1999-11-24
TR199900856T2 (xx) 1999-07-21
BR9713338B1 (pt) 2009-12-01
EE03829B1 (et) 2002-08-15
NO312764B1 (no) 2002-07-01
HK1022151A1 (en) 2000-07-28
PL189641B1 (pl) 2005-09-30
JP4223075B2 (ja) 2009-02-12
CA2270964C (en) 2007-07-31
KR20000053100A (ko) 2000-08-25
SK62399A3 (en) 1999-10-08
JP2001503442A (ja) 2001-03-13
RS49607B (sr) 2007-06-04
HU226981B1 (hu) 2010-04-28
ID22042A (id) 1999-08-26
NO992282D0 (no) 1999-05-11
DK0937074T3 (da) 2003-06-23
AU733129B2 (en) 2001-05-10
NO992282L (no) 1999-05-11
CZ288752B6 (cs) 2001-08-15
AU5317098A (en) 1998-06-03
WO1998021208A1 (en) 1998-05-22
IL129054A0 (en) 2000-02-17
GEP20012390B (en) 2001-03-25
DE69719778T2 (de) 2004-02-05
ATE234300T1 (de) 2003-03-15
HUP0000426A3 (en) 2001-04-28
EA001551B1 (ru) 2001-04-23
US6008215A (en) 1999-12-28
NZ334976A (en) 2000-10-27
YU19499A (sh) 2001-09-28
CZ167599A3 (cs) 1999-11-17
EP0937074B1 (en) 2003-03-12
BR9713338A (pt) 2000-05-09
HUP0000426A2 (hu) 2001-02-28
SI0937074T1 (en) 2003-08-31
CY2476B1 (en) 2005-05-03
BG103310A (en) 2000-05-31
BG63695B1 (bg) 2002-09-30
KR100484045B1 (ko) 2005-04-20
CA2270964A1 (en) 1998-05-22
IL129054A (en) 2002-07-25
PL333429A1 (en) 1999-12-06
DE69719778D1 (de) 2003-04-17
ES2195189T3 (es) 2003-12-01
EP0937074A1 (en) 1999-08-25
CN1090188C (zh) 2002-09-04
EA199900421A1 (ru) 1999-10-28

Similar Documents

Publication Publication Date Title
EE9900105A (et) Bensonaftüridiinid bronhiaalravimitena
CA2297911A1 (en) Substituted 6-phenylphenanthridines
DK0772610T3 (da) Dihydrobenzofuraner
BR9707233A (pt) Fenantridinas
DE69918422D1 (de) Phthalazinone pde iii/iv hemmer
DK0998460T3 (da) Hidtil ukendte tetrazolderivater
AU2291097A (en) Novel phenanthridines substituted in the 6 position
ATE233252T1 (de) Substituierte dihydrobenzofurane als pde- hemmstoffe
PT920426E (pt) Novos derivados de tiazole com efeito inibidor de fosfodiesterase
DE69821530D1 (de) Dihydrobenzifurane
PT1086096E (pt) Benzamidas com substituintes etra-hidrofuraniloxi como inibidores da fosfodiesterase 4
DE60025327D1 (de) 6-arylphenanthridine mit pde-iv hemmender wirkung
DK1204659T3 (da) Serotonerge benzofuraner
SI0937075T1 (en) New Imidazo- and Oxazolopyridines as Phosphodiesterase Inhibitors.
AU758194C (en) Novel benzimidazoles and benzoxazoles

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20021231

KB4A Valid patent at the end of a year

Effective date: 20031231

KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

HC1A Change of owner name
KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20091231

KB4A Valid patent at the end of a year

Effective date: 20101231

MM4A Lapsed by not paying the annual fees

Effective date: 20151105